US Patent Issued to University of Tsukuba, TNAX Biopharma on July 29 for "Humanized anti-DNAM-1 antibody" (Japanese, British Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,495, issued on July 29, was assigned to University of Tsukuba (Tsukuba, Japan) and TNAX Biopharma Corp. (Tsukuba, Japan).

"Humanized anti-DNAM-1 antibody" was invented by Akira Shibuya (Tsukuba, Japan), Kazuko Shibuya (Tsukuba, Japan), Yumi Kanemaru (Cambridge, Great Britain) and Fumie Abe (Tsukuba, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "One aspect of the present invention is a humanized anti-DNAM-1 antibody or an antigen-binding fragment thereof, including: a heavy chain variable region containing an amino acid sequence of SEQ ID NO: 1 as HCDR1, an amino acid sequence of SEQ ID NO: 2 as HCDR2, and an amino acid sequence of SEQ ID NO: ...